跳至主要内容
临床试验/NCT00377832
NCT00377832终止不适用

Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial

Weill Medical College of Cornell University1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2007年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
13
试验地点
1
主要终点
Baseline Fetal Heart Rate (FHR) After Treatment

研究概览

简要总结

The most common cause of fetal tachycardia is maternal fever. Fetal tachycardia often precedes the maternal fever, and fetal tachycardia confounds the interpretation of electronic fetal monitoring (EFM), increasing the rate of cesarean delivery for non-reassuring fetal status (NRFS). Our hypothesis is that treatment of fetal tachycardia with acetaminophen will significantly lower maternal body temperature and significantly lower baseline fetal heart rate (FHR). The importance is that interpretation of EFM will improve, thus allowing for a decrease in cesarean delivery for NRFS.

详细描述

This trial is a randomized, non-placebo controlled, assessment of whether acetaminophen can lower maternal temperature and baseline fetal heart rate in laboring patients with fetal tachycardia.

Term singleton cephalic pregnancies in active phase labor (spontaneous or induced) with fetal tachycardia will be recruited. Patient will be excluded for:

  • Exclusion criteria (prior to randomization):
  • Acetaminophen allergy
  • Clinical chorioamnionitis
  • Maternal fever
  • Non-reassuring fetal status (NRFS), which is the designation for fetal heart rate abnormalities requiring cesarean delivery
  • Previous cesarean delivery
  • Multifetal gestation
  • Breech presentation
  • Known fetal anomaly
  • Known contraindication to vaginal delivery

Primary outcome measures are:

  1. Maternal body temperature (oral) 90 minutes after treatment
  2. Baseline FHR

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Term pregnancy
  • Singleton pregnancy
  • Pregnancy with cephalic presentation
  • Pregnancy in active phase labor
  • Fetal tachycardia

排除标准

  • Acetaminophen allergy
  • Clinical chorioamnionitis
  • Maternal fever
  • Non-reassuring fetal status or fetal heart rate abnormalities requiring cesarean delivery
  • Previous cesarean delivery
  • Multifetal gestation
  • Breech presentation
  • Known fetal anomaly
  • Known contraindication to vaginal delivery

研究组 & 干预措施

2

Active Comparator

Acetaminophen 975 mg once

干预措施: Acetaminophen 975 mg (Drug)

结局指标

主要结局

Baseline Fetal Heart Rate (FHR) After Treatment

时间窗: 90 minutes

Maternal Body Temperature 90 Minutes After Randomization

时间窗: 90 minutes

Fever in labor is identified,consenting and randomization occurs, either acetaminophen is given or no medication is given, then 90 minutes later maternal temperature is recorded.

次要结局

  • Temperature Difference Before and After Treatment(90 minutes)
  • Rate of Cesarean Delivery(Labor--up to 24 hours)
  • Rate of Determination of Non-reassuring Fetal Status(Labor--up to 24 hours)
  • Rate of Subsequent Development of Maternal Fever(Labor--up to 24 hours)
  • Rate of Diagnosis of Clinical Chorioamnionitis(Labor--up to 24 hours)
  • Rate of Neonatal Sepsis(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Acetaminophen for Fetal Tachycardia: a Randomized... | 临床试验